The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule production in Sofia - have Nivalin in common, one of the strongest Sopharma products. Nivalin is sold in more than 10 countries outside Bulgaria, making it one of the most famous Sopharma products. It increases the intensity of the reflex centers of the spinal cord, medulla oblongata and cerebral cortex, thus influences all links of the reflex arc.
Sofia, Bulgaria, June 2, 2023 – In accordance with the requirements of art. 115c, para. 4 of LPOS “Sopharma” AD notifies all shareholders of the Company about the decision of the AGM of “Sopharma” AD that took place on June 2, 2023 regarding the amount and type of dividend distributed and the terms and conditions for its distribution:
The AGM approves the proposal by the Board of Directors for the distribution of gross dividend at the amount of 0.60 BGN /sixty stotinki / per share.
Sofia, Bulgaria, June 1, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that at its meeting the Board of Directors decided to conduct a detailed analysis of potential opportunities for acquisition of shares in the capital of companies engaged in the production and/or marketing of medicinal products, food supplements, medical devices and/or other goods of importance to human health on the territory of the Republic of Serbia.
